Back to Trials
NCT05889546Recruiting

Rapid Autopsy Protocol for Patients With Small Cell Lung Cancer

Indiana University

Start Date

8/31/2022

Completion Date

12/31/2031

Summary

This is pilot study to establish a rapid autopsy program in Small Cell Lung Cancer (SCLC) at the Indiana University Simon Comprehensive Cancer Center and outline the components necessary for tumor tissue collection.

Detailed Description

The goal of this project to establish a rapid autopsy program in SCLC at the IUSCCC and outline the key components necessary for tumor tissue acquisition. This proposal is a collaboration between scientists, lung cancer physicians, pathologists, and the IUSCCC Translational Research Core. Tumor tissue collected will be used for protein and gene analysis and RNA, whole exome sequencing in addition to the establishment of SCLC. This research is part of a discovery project in which biological and molecular markers of SCLC will be identified.

Eligibility Criteria

Age Range: 18 years to No maximum

Inclusion Criteria: 1. ≥ 18 years old at the time of informed consent 2. Written informed consent and HIPAA authorization for release of personal health information. 3. Active SCLC diagnosis.

Interventions

PROCEDURE

Biospecimen Collection

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Small Cell Lung Cancer

Locations

Indiana University Melvin and Bren Simon Comprehensive Cancer Center

Indianapolis, Indiana 46202

United States

Roudebush VA Medical Center

Indianapolis, Indiana 46202

United States

Sidney and Lois Eskenazi Hospital

Indianapolis, Indiana 46202

United States